Thrombosis, Neuroinflammation, and Poststroke Infection: The Multifaceted Role of Neutrophils in Stroke

Abstract EN

Immune cells can significantly predict and affect the clinical outcome of stroke.

In particular, the neutrophil-to-lymphocyte ratio was shown to predict hemorrhagic transformation and the clinical outcome of stroke; however, the immunological mechanisms underlying these effects are poorly understood.

Neutrophils are the first cells to invade injured tissue following focal brain ischemia.

In these conditions, their proinflammatory properties enhance tissue damage and may promote ischemic incidences by inducing thrombus formation.

Therefore, they constitute a potential target for therapeutic approaches and prevention of stroke.

Indeed, in animal models of focal brain ischemia, neutrophils have been targeted with successful results.

However, even in brain lesions, neutrophils also exert beneficial effects, because they are involved in triggering immunological removal of cell debris.

Furthermore, intact neutrophil function is essential for maintaining immunological defense against bacterial infections.

Several studies have demonstrated that stroke-derived neutrophils displayed impaired bacterial defense capacity.

Because infections are known to impair the clinical course of stroke, therapeutic interventions that target neutrophils should preserve or even restore their function outside the central nervous system (CNS).

This complex situation requires well-tailored therapeutic approaches that can effectively tackle immune cell invasion in the brain but avoid increasing poststroke infections.